Description
An IDO pathway inhibitor (Ki = 7 nM; EC50 = 75 nM); inhibits IDO-induced T cell suppression and restores T cell response during allogenic mixed lymphocyte reactions in vitro; induces a 95% reduction in tumor volume when given in conjunction with a pmel-1 T cell vaccine in vivo ,
Formal name: α-cyclohexyl-5H-imidazo[5,1-a]isoindole-5-ethanol
Synonyms: GDC-0919
Molecular weight: 282.4
CAS: 1402836-58-1
Purity: ≥98% (mixture of enantiomers)
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer||Research Area|Immunology & Inflammation|Adaptive Immunity